94 related articles for article (PubMed ID: 2519427)
41. Furosemide kinetics in patients with hepatic cirrhosis with ascites.
Fuller R; Hoppel C; Ingalls ST
Clin Pharmacol Ther; 1981 Oct; 30(4):461-7. PubMed ID: 7285480
[TBL] [Abstract][Full Text] [Related]
42. Renal prostacyclin influences renal function in non-azotemic cirrhotic patients treated with furosemide.
Quiroga J; Zozaya JM; Labarga P; Rodríguez-Ortigosa CM; Milazzo A; Prieto J
J Hepatol; 1991 Mar; 12(2):170-5. PubMed ID: 2050996
[TBL] [Abstract][Full Text] [Related]
43. Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure.
Ginès A; Salmerón JM; Ginès P; Arroyo V; Jiménez W; Rivera F; Rodés J
J Hepatol; 1993 Feb; 17(2):220-6. PubMed ID: 8445236
[TBL] [Abstract][Full Text] [Related]
44. Effects of imidazole-salicylate on renal function and the diuretic action of furosemide in cirrhotic patients with ascites.
Salerno F; Lorenzano E; Maggi A; Badalamenti S; Minuz P; Degan M; Chinea B; Scotti A
J Hepatol; 1993 Sep; 19(2):279-84. PubMed ID: 8301062
[TBL] [Abstract][Full Text] [Related]
45. Mobilization of ascites in cirrhotic dogs following furosemide or mannitol diuresis.
Levy M; Richard C
Am J Physiol; 1978 Jul; 235(1):F12-21. PubMed ID: 677315
[TBL] [Abstract][Full Text] [Related]
46. [2nd place in the competition of scientific papers in hepatology 2012].
Fedulenkova LV
Eksp Klin Gastroenterol; 2012; (5):113-8. PubMed ID: 23402182
[TBL] [Abstract][Full Text] [Related]
47. Pathophysiology and treatment of ascites in cirrhosis.
La Villa G; Arroyo V
Trop Gastroenterol; 1990; 11(2):56-75. PubMed ID: 2219443
[TBL] [Abstract][Full Text] [Related]
48. Comparative Study of Slow Infusion versus Bolus Doses of Albumin and Furosemide Infusion to Mobilize Refractory Ascites in Decompensated Chronic Liver Disease.
Pathak R; Yadav AK; Thapaliya S; Kafle B; Jha A; Khadga P
J Nepal Health Res Counc; 2020 Sep; 18(2):233-237. PubMed ID: 32969384
[TBL] [Abstract][Full Text] [Related]
49. Furosemide Dose Changes Associated with Furosemide/Tolvaptan Combination Therapy in Patients with Cirrhosis.
Uojima H; Hidaka H; Tanaka Y; Wada N; Kubota K; Nakazawa T; Shibuya A; Sung JH; Kako M; Koizumi W
Dig Dis; 2020; 38(1):38-45. PubMed ID: 31216537
[TBL] [Abstract][Full Text] [Related]
50. Effect of sulindac on prostaglandin excretion and renal function in cirrhotic patients with ascites.
Guarner C; Enriquez J; Guarner F; Quiroga J; Just J; Seres I; Prieto J; Vilardell F
Scand J Gastroenterol; 1986 Mar; 21(2):231-4. PubMed ID: 3715390
[TBL] [Abstract][Full Text] [Related]
51. [Renal function during acute expansion of plasma volume. Reinfusion of concentrated ascitic fluid in hepatic cirrhosis].
Novarini A; Bruschi G; Coruzzi P; Guariglia A; Mutti A; Pasetti GC; Perinotto P; Borghetti A
Minerva Nefrol; 1976; 23(2):116-25. PubMed ID: 1004790
[No Abstract] [Full Text] [Related]
52. Pharmacokinetics of furosemide in patients with hepatic cirrhosis.
González G; Arancibia A; Rivas MI; Caro P; Antezana C
Eur J Clin Pharmacol; 1982; 22(4):315-20. PubMed ID: 7106167
[TBL] [Abstract][Full Text] [Related]
53. Midodrine and furosemide-induced natriuresis in cirrhotics with ascites.
Kalambokis G; Tsianos EV
Aliment Pharmacol Ther; 2011 Feb; 33(3):415-6. PubMed ID: 21198702
[No Abstract] [Full Text] [Related]
54. Effect of triamterene on potassium excretion in cirrhotic patients receiving furosemide.
Thompson EJ; Torres E; Grosberg SJ; Martinez-Maldonado M
Clin Pharmacol Ther; 1977 Apr; 21(4):392-4. PubMed ID: 321176
[TBL] [Abstract][Full Text] [Related]
55. Inability of glucagon to increase glomerular filtration rate in dogs with experimental cirrhosis and ascites.
Levy M
Can J Physiol Pharmacol; 1978 Jun; 56(3):511-4. PubMed ID: 667727
[TBL] [Abstract][Full Text] [Related]
56. Enhancement of renal function by a long-acting somatostatin analogue in patients with decompensated cirrhosis.
Mountokalakis T; Kallivretakis N; Mayopoulou-Symvoulidou D; Karvountzis G; Tolis G
Nephrol Dial Transplant; 1988; 3(5):604-7. PubMed ID: 3146715
[TBL] [Abstract][Full Text] [Related]
57. [The relationship between plasma procalcitonin, endotoxin and renal function status in patients with cirrhotic ascites].
Zhang W; Chen LM; Zhang SL; Wang HB
Zhonghua Gan Zang Bing Za Zhi; 2003 Dec; 11(12):758. PubMed ID: 14697146
[No Abstract] [Full Text] [Related]
58. Effect of simultaneous administration of glucagon and insulin on renal function in patients with liver cirrhosis and ascites.
Hattori K; Hasumura Y; Takeuchi J
Gastroenterol Jpn; 1984 Feb; 19(1):59-64. PubMed ID: 6373477
[TBL] [Abstract][Full Text] [Related]
59. [Changes in renal venous pressure and the parameters of renal function during the paracentesis-concentration-reinjection of ascites].
Bataille C; Kinet JP; Godon JP
Acta Gastroenterol Belg; 1982; 45(3-4):122-3. PubMed ID: 7148344
[No Abstract] [Full Text] [Related]
60. Treatment of hepatorenal syndrome.
Schwartz ML; Vogel SB
Am J Surg; 1980 Mar; 139(3):370-3. PubMed ID: 7362005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
